Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Knight Therapeutics Inc.
  6. Calendar
    GUD   CA4990531069

KNIGHT THERAPEUTICS INC.

(GUD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart KNIGHT THERAPEUTICS INC.
Upcoming events on KNIGHT THERAPEUTICS INC.
11/11/21 Q3 2021 Earnings Release (Projected)
03/17/22 FY 2021 Earnings Release (Projected)
05/12/22 Q1 2022 Earnings Release (Projected)
08/11/22 Interim 2022 Earnings Release (Projected)
Past events on KNIGHT THERAPEUTICS INC.
08/13/21 | 08:30am Interim 2021 Earnings Call
08/13/21 | 07:40am Interim 2021 Earnings Release
08/11/21 | 03:00pm Canaccord Genuity Growth Conference
06/02/21 | 10:30am Jefferies Healthcare Conference
05/18/21 | 08:35am RBC Capital Markets Healthcare Conference
05/14/21 | 08:30am Q1 2021 Earnings Call
05/14/21 | 07:30am Q1 2021 Earnings Release
05/13/21 | 09:00am Annual General Meeting
04/23/21 | 08:30am Acquisition of Rights to Manufacture, Market and Sell Exelon« by Knight Therapeutics Inc Call
04/20/21 | 09:30am Bloom Burton & Co. Healthcare Investor Conference
Past dividends on KNIGHT THERAPEUTICS INC.

- No events available -

Annual results
Fiscal Period : December201620172018201920202021
Sales
M CAD
Released
Forecast
Spread
5,94
5,50
8,0%
8,63
8,30
4,0%
12,5
11,3
11%
47,5
41,9
13%
200
192
3,7%
 
237
 
Operating income
(EBITDA)
M CAD
Released
Forecast
Spread
-7,40
-6,64
-11%
-7,28
-7,77
6,4%
-3,85
-3,87
0,54%
-9,24
-11,0
16%
16,8
16,4
2,8%
 
37,0
 
Operating profit
(EBIT)
M CAD
Released
Forecast
Spread
-7,84
-7,59
-3,3%
-8,91
-9,84
9,5%
-5,78
-6,39
9,5%


 
-4,47
0,89
-601%
 
31,0
 
Pre-Tax Profit
(EBT)
M CAD
Released
Forecast
Spread
23,5
20,5
14%
21,2
19,9
6,5%
29,5
34,1
-14%
22,8
33,2
-31%
32,1
24,7
30%
 
35,7
 
Net income
M CAD
Released
Forecast
Spread
18,6
16,1
15%
17,2
16,7
3,3%
24,1
28,1
-14%
14,5
27,1
-46%
42,1
30,9
36%
 
33,5
 
EPS
CAD
Released
Forecast
Spread
0,15
0,13
17%
0,12
0,12
1,7%
0,17
0,19
-12%
0,10
0,19
-46%
0,32
0,24
35%
 
0,29
 
Announcement Date03/16/201703/15/201803/14/201903/30/202003/25/2021-
Quarterly results
Fiscal Period : December2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
Sales
M CAD
Released
Forecast
Spread
53,3
50,8
4,8%
45,2
51,6
-12%
55,2
49,0
13%
46,1
48,7
-5,4%
65,8
50,3
31%
 
58,7
 
Operating income
(EBITDA)
M CAD
Released
Forecast
Spread
2,70
0,39
594%
-4,77
6,23
-177%
1,77
3,77
-53%
5,58
3,45
62%
9,40
4,55
107%
 
9,86
 
Operating profit
(EBIT)
M CAD
Released
Forecast
Spread


 
-11,9

 
-3,71
1,65
-325%
3,07
-1,21
354%
7,65
3,00
155%
 
9,18
 
Pre-Tax Profit
(EBT)
M CAD
Released
Forecast
Spread
14,6
-3,52
515%
17,1
-0,28
6 201%
10,9
2,60
318%
4,43
-2,85
255%
26,6
-8,35
418%
 
0,65
 
Net income
M CAD
Released
Forecast
Spread
17,4
-6,17
383%
18,1
-1,10
1 740%
8,23
2,57
220%
3,56
-4,50
179%
29,0
-2,00
1 553%
 
-0,34
 
EPS
CAD
Released
Forecast
Spread
0,13
-0,03
620%
0,14
0,00
3 350%
0,06
0,01
373%
0,03
-0,03
207%
0,23
-0,07
414%
 
0,02
 
Announcement Date08/13/202011/13/202003/25/202105/14/202108/13/2021-
Previous year Next Year
Upcoming sector events for KNIGHT THERAPEUTICS INC.

- No events available -

More events
Past sector events for KNIGHT THERAPEUTICS INC.

- No events available -

More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise